The TAILORx study

Sara M. Tolaney, MD, MPH, talks about the TAILORx study in HR+, HER2-, node-negative, intermediate 21-gene recurrence score patients, means endocrine therapy alone is similar in efficacy to chemoendoc... Author: obr Added: 07/19/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts